MedTrace Logo

Safety and Efficacy of a Natural Health Product in Reducing Cholesterol and Triglyceride Levels.

NCT01028274 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 148

Last updated 2015-12-14

No results posted yet for this study

Summary

The purpose of this study is to assess the safety and efficacy of a natural health product among participants with elevated LDL cholesterol and triglyceride levels.

Conditions

  • LDL Cholesterol
  • Triglycerides

Interventions

DIETARY_SUPPLEMENT

Placebo

Two capsules, twice daily with meals for 12 weeks.

DIETARY_SUPPLEMENT

Investigational Product 1

Two capsules, twice daily with meals for 12 weeks.

DIETARY_SUPPLEMENT

Investigational Product 2

Two capsules, twice daily with meals for 12 weeks.

Sponsors & Collaborators

  • Nutrasource Pharmaceutical and Nutraceutical Services, Inc.

    collaborator NETWORK

  • Nordic Pharma, USA

    lead INDUSTRY

Principal Investigators

  • Maggie Laidlaw, Ph.D. Candidate · Nutrasource Pharmaceutical and Nutraceutical Services, Inc.

  • Brad West, ND · Nordic Naturals

  • Steven Traplin, MD · Nutrasource Pharmaceutical and Nutraceutical Services, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2010-06-30
Completion
2010-08-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01028274 on ClinicalTrials.gov